HOLLISTON, Mass., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that its Chief Executive Officer, Jeffrey A. Duchemin, has been appointed by the Board of Directors to the additional positions of President and Director, effective immediately. He replaces David Green, who has become President at Harvard Apparatus Regenerative Technology, Inc. (HART), which was spun off from HBIO on November 1, 2013. Mr. Green will remain on the Board of Directors of Harvard Bioscience.
Help employers find you! Check out all the jobs and post your resume.
